Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Assa Oumie"'
Autor:
E Tinkler-Hundal, Fiona Brew, Philip Quirke, Karen G. Spink, Fiona S. Togneri, Paula Wojtowicz, M Taylor, Assa Oumie, Henry M. Wood, Joseph M. Foster
Publikováno v:
BMC Medical Genomics
Background The importance of accurate and affordable mutation calling in fixed pathology samples is becoming increasingly important as we move into the era of personalised medicine. The Affymetrix OncoScan® Array platform is designed to produce acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71180b169e6b356e1df906b536ac89ea
https://doi.org/10.1186/s12920-017-0254-5
https://doi.org/10.1186/s12920-017-0254-5
Autor:
Floriane Laurent, Emma Stanley, Maureen West, Amrik Basran, Emma Jenkins, Jennifer Hillman, Jyrki Sivula, Estelle Adam, Lisa Strong, Michele Writer, Assa Oumie
Publikováno v:
Cancer Research. 79:2248-2248
Programmed Cell Death-Ligand 1 (PD-L1) binds to its receptor, Programmed Cell Death protein (PD-1) and is expressed on both a range of activated immune cells and tumor cells. Lymphocyte Activation Gene-3 (LAG-3) is a member of the Ig superfamily and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec754c93c9a5c2ec1ca6c0f814351f10
https://doi.org/10.1158/1538-7445.am2019-2248
https://doi.org/10.1158/1538-7445.am2019-2248
Autor:
Viviana Robles-munoz, Estelle Adam, Jennifer Hillman, Emma Jenkins, Assa Oumie, Maureen West, Jyrki Sivula, Amrik Basran, Michele Writer, Emma Stanley, Floriane Laurent
Publikováno v:
Cancer Research. 79:4108-4108
Programmed Cell Death-Ligand 1 (PD-L1) binds to its receptor, Programmed Cell Death protein (PD-1) and is expressed on a range of activated immune cells and is upregulated by tumor cells and by immune cells in the tumor microenvironment. PD-L1 immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70909b908eec3dd174e40de2f2bef46f
https://doi.org/10.1158/1538-7445.am2019-4108
https://doi.org/10.1158/1538-7445.am2019-4108
Autor:
Brendan O'Sullivan, Sofia Alyas, Philippe Taniere, Nayneeta Deshmukh, Mike Griffiths, Fabiana Ramos Vasques, Paula Wojtowicz, Adam J. Devall, Joseph M. Foster, Dominic J. McMullan, Karen G. Spink, Nicholas D. James, Richard T. Bryan, Maurice P. Zeegers, Douglas G. Ward, Kar Keung Cheng, Fiona S. Togneri, Assa Oumie
Publikováno v:
European Journal of Human Genetics
European Journal of Human Genetics, 24(8). Nature Publishing Group
European Journal of Human Genetics, 24(8). Nature Publishing Group
Urothelial bladder cancers (UBCs) have heterogeneous clinical characteristics that are mirrored in their diverse genomic profiles. Genomic profiling of UBCs has the potential to benefit routine clinical practice by providing prognostic utility above
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47934a7bfb1319ecc2cae89f5aafc42a
https://doi.org/10.1038/ejhg.2015.281
https://doi.org/10.1038/ejhg.2015.281
Autor:
Garikai Kushinga, Hara Keisuke, Magdalena Sztyler, Daizo Kurishita, Yasuhiro Oshima, Tomoaki Kurakazu, Sakina Gooljar, Assa Oumie, Tomohisa Nagata, R.P. Baptista, Marc-Olivier Baradez, Celia Murray-Dunning, Hannah Smith, Rhys Macown, Beverly Vaughan
Publikováno v:
Cytotherapy. 19:e19-e20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7f183b30400d1f39452e4e3170a4558
https://doi.org/10.1016/j.jcyt.2017.03.047
https://doi.org/10.1016/j.jcyt.2017.03.047
Autor:
Fabiana Ramos Vasques, Phil Quirke, Fiona S. Togneri, Katherine E. Keating, Iris Halfpenny, Karen G. Spink, M Taylor, Debra Hau, Dominic J. McMullan, Fiona Brew, Paul Wallace Medlow, E Tinkler-Hundal, K Southward, Joseph M. Foster, Michael J. Griffiths, Keith McGreeghan-Crosby, Assa Oumie
Publikováno v:
BMC Medical Genomics
Background Adoption of new technology in both basic research and clinical settings requires rigorous validation of analytical performance. The OncoScan® FFPE Assay is a multiplexing tool that offers genome-wide copy number and loss of heterozygosity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc93aca624e6f024eb27c9997d7937d8
https://doi.org/10.1186/s12920-015-0079-z
https://doi.org/10.1186/s12920-015-0079-z
Publikováno v:
Cytotherapy. 19:S41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a972c11e8961ab05d1dcd33fb3bf229
https://doi.org/10.1016/j.jcyt.2017.02.096
https://doi.org/10.1016/j.jcyt.2017.02.096
Autor:
G. Kushinga, Assa Oumie, J. Guijarro-Leach, S. Senderovich, D. Marshall, M. Francois, D. Grandolfo, R. Macown, N. Nicholas, M. Baradez, R.P. Baptista
Publikováno v:
Cytotherapy. 19:S107
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fab359df5ce605c7f9396bc4218bd02
https://doi.org/10.1016/j.jcyt.2017.02.161
https://doi.org/10.1016/j.jcyt.2017.02.161
Autor:
Dominic J. McMullan, Eric T. Fung, M Taylor, Phil Quirke, Karen G. Spink, Michael J. Griffiths, Sofia Alyas, Katherine E. Keating, Fiona S. Togneri, E Tinkler-Hundal, Paula Wojtowicz, Jeanette Schmidt, Joseph M. Foster, K Southward, Henry M. Wood, Assa Oumie, Fiona Brew
Publikováno v:
Cancer Research. 75:626-626
Objectives Copy number (CN) and somatic mutation (SM) analysis in tumors is rapidly gaining importance in cancer management as a tool for differential diagnosis, determination of prognosis, and selection of therapeutic. Genome-wide copy number and LO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3d3ff855a974cf9a7eb65a620c097bd
https://doi.org/10.1158/1538-7445.am2015-626
https://doi.org/10.1158/1538-7445.am2015-626